News
At Cell-Easy, we provide end-to-end GMP manufacturing services for advanced therapy medicinal products (ATMPs), with a strong focus on compliance, scalability, and reliability.
We help biotech and pharma companies bring innovative cell therapies from the lab to the clinic by combining high-quality starting material sourcing, robust process development, and clinical-grade GMP production that meets international standards (MHRA, ANSM, EMA, FDA readiness).
Whether you need early clinical batches or large-scale production, our tailored solutions optimize your process, minimize risks, and accelerate time-to-clinic.
CHU Toulouse and Cell-Easy Receive Regulatory Approval of A3D: A Phase 1 Trial Using CellReady® in Alzheimer’s Disease
Learn more: CHU Toulouse and Cell-Easy Receive Regulatory Approval of A3D: A Phase 1 Trial Using CellReady® in Alzheimer’s DiseaseCHU Toulouse and Cell-Easy Receive Regulatory Approval of A3D: A Phase 1 Trial Using CellReady® in Alzheimer’s Disease Cell-Easy, a
Cell-Easy Expands its GMP Cell Therapy Manufacturing Facility to Support Growing Client Demand
Learn more: Cell-Easy Expands its GMP Cell Therapy Manufacturing Facility to Support Growing Client DemandCell-Easy Expands its GMP Cell Therapy Manufacturing Facility to Support Growing Client Demand New state-of-the-art class-B cleanrooms, development labs, and
CTA Approval to initiate ALLOFIST
Learn more: CTA Approval to initiate ALLOFISTCTA Approval to initiate ALLOFIST CHU Toulouse receives CTA Approval to initiate ALLOFIST, a Phase 1/2 Trial based on Cell-Easy’s
Mastering Cell Bank Development and Manufacturing Services for US Pharma company
Learn more: Mastering Cell Bank Development and Manufacturing Services for US Pharma companyMastering Cell Bank Development and Manufacturing Services for US Pharma company Cell-Easy Expands US Footprint with Key Contract Signing for
Cell-Easy Signs Groundbreaking Manufacturing Contract, Paving the Way for Local Hospitals to Offer Next-Generation CAR-T Therapy
Learn more: Cell-Easy Signs Groundbreaking Manufacturing Contract, Paving the Way for Local Hospitals to Offer Next-Generation CAR-T TherapyCell-Easy Signs Groundbreaking Manufacturing Contract, Paving the Way for Local Hospitals to Offer Next-Generation CAR-T Therapy This agreement with a
Accelerating Patient Access to Advanced Cell-based Therapies through the Signature of a Service Agreement between the French CDMO and the Toulouse University Hospital (CHU Toulouse)
Learn more: Accelerating Patient Access to Advanced Cell-based Therapies through the Signature of a Service Agreement between the French CDMO and the Toulouse University Hospital (CHU Toulouse)Accelerating Patient Access to Advanced Cell-based Therapies through the Signature of a Service Agreement between the French CDMO and the